{"altmetric_id":2190736,"counts":{"readers":{"mendeley":23,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["Senology"],"posts_count":1}},"selected_quotes":["Checkpoint kinase 1 (Chk1) may represent a potent therapeutic target in triple-negative breast cancer #cancer #breast"],"citation":{"abstract":"Bioinformatics analyses of pathways and genes differentially expressed between malignant and benign lesions could allow discovering new therapeutic targets. Here, we identified Checkpoint kinase 1 (Chk1) as a potent therapeutic target in triple-negative breast cancer (TNBC).","abstract_source":"pubmed","altmetric_jid":"4f6fa60f3cf058f610006cfb","doi":"10.1016\/j.breast.2014.02.004","first_seen_on":"2014-03-17T15:56:48+00:00","issns":["09609776"],"journal":"The Breast","last_mentioned_on":1395071450,"links":["http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0960977614000320"],"pmid":"24636978","publisher":"Elsevier Ltd","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"title":"Chk1 as a new therapeutic target in triple-negative breast cancer","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/chk1-new-therapeutic-target-triplenegative-breast-cancer"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4508612,"mean":5.1916753366762,"rank":3034985,"this_scored_higher_than_pct":20,"this_scored_higher_than":905467,"rank_type":"exact","sample_size":4508612,"percentile":20},"similar_age_3m":{"total_number_of_other_articles":111883,"mean":8.0503000661413,"rank":73469,"this_scored_higher_than_pct":20,"this_scored_higher_than":22385,"rank_type":"exact","sample_size":111883,"percentile":20},"this_journal":{"total_number_of_other_articles":316,"mean":2.9767936507937,"rank":200,"this_scored_higher_than_pct":19,"this_scored_higher_than":61,"rank_type":"exact","sample_size":316,"percentile":19},"similar_age_this_journal_3m":{"total_number_of_other_articles":7,"mean":1.9583333333333,"rank":5,"this_scored_higher_than_pct":14,"this_scored_higher_than":1,"rank_type":"exact","sample_size":7,"percentile":14}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Professor > Associate Professor":2},"by_discipline":{"Agricultural and Biological Sciences":1,"Biochemistry, Genetics and Molecular Biology":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/Senology\/status\/445588073712476160","license":"public","citation_ids":[2190736],"posted_on":"2014-03-17T15:50:50+00:00","author":{"name":"Senology","url":"http:\/\/www.senology.org","image":"https:\/\/pbs.twimg.com\/profile_images\/1301293396\/logo_style_normal.JPG","description":"Senology.org is the official web site of the International Senologic and Oncologic Scientific Community (ISOSC) - breast diseases and cancer diagnosis and care","id_on_source":"Senology","tweeter_id":"203469783","geo":{"lt":null,"ln":null},"followers":1871},"tweet_id":"445588073712476160"}]}}